-
Share
7,337 Posts.
805
06/01/20
10:49
Share
Its animal pharma peers are at least 10x its current market cap. And now they have a globally exclusive CSIRO delivery mechanism to boot.
New 52 week high, but still hardly any shares on issue, with the Top 20 owning about 70%.